Publikationen in Zusammenarbeit mit Forschern von Charité (13)

2020

  1. H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts

    Clinical Epigenetics, Vol. 12, Núm. 1

  2. Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction

    Circulation, Vol. 141, Núm. 9, pp. 751-767

2019

  1. Correction: Arterial tortuosity syndrome: 40 new families and literature review (Genetics in Medicine, (2018), 20, 10, (1236-1245), 10.1038/gim.2017.253)

    Genetics in Medicine

2018

  1. Arterial tortuosity syndrome: 40 new families and literature review

    Genetics in Medicine, Vol. 20, Núm. 10, pp. 1236-1245

  2. Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial

    European Journal of Heart Failure, Vol. 20, Núm. 9, pp. 1290-1299

  3. Immunomodulation by adoptive regulatory T-cell transfer improves Coxsackievirus B3-induced myocarditis

    FASEB Journal, Vol. 32, Núm. 11, pp. 6066-6078

  4. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial)

    European Journal of Heart Failure, Vol. 20, Núm. 3, pp. 460-470

  5. Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 33, Núm. 2, pp. ii4-ii14

2017

  1. Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction

    Cardiovascular Research, Vol. 113, Núm. 8, pp. 906-914

2016

  1. Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment

    Nature Communications, Vol. 7

2013

  1. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model

    Circulation: Heart Failure, Vol. 6, Núm. 6, pp. 1239-1249

  2. Osteopontin-mediated myocardial fibrosis in heart failure: A role for lysyl oxidase?

    Cardiovascular Research, Vol. 99, Núm. 1, pp. 111-120

2011

  1. Diastolic tissue doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction

    Journal of the American College of Cardiology, Vol. 57, Núm. 8, pp. 977-985